|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM112268498 |
| 003 |
DE-627 |
| 005 |
20231222161404.0 |
| 007 |
tu |
| 008 |
231222s2001 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0375.xml
|
| 035 |
|
|
|a (DE-627)NLM112268498
|
| 035 |
|
|
|a (NLM)11318592
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Tkaczyk, C
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Fc(epsilon)Ri-dependent signaling pathways in human mast cells
|
| 264 |
|
1 |
|c 2001
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 31.05.2001
|
| 500 |
|
|
|a Date Revised 24.11.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
7 |
|a Cytokines
|2 NLM
|
| 650 |
|
7 |
|a Enzyme Precursors
|2 NLM
|
| 650 |
|
7 |
|a Intracellular Signaling Peptides and Proteins
|2 NLM
|
| 650 |
|
7 |
|a Receptors, IgE
|2 NLM
|
| 650 |
|
7 |
|a Phosphatidylinositol 3-Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.1.-
|2 NLM
|
| 650 |
|
7 |
|a Protein-Tyrosine Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.1
|2 NLM
|
| 650 |
|
7 |
|a SYK protein, human
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.2
|2 NLM
|
| 650 |
|
7 |
|a Syk Kinase
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.2
|2 NLM
|
| 650 |
|
7 |
|a Syk protein, mouse
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.2
|2 NLM
|
| 650 |
|
7 |
|a lyn protein-tyrosine kinase
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.2
|2 NLM
|
| 650 |
|
7 |
|a src-Family Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.10.2
|2 NLM
|
| 650 |
|
7 |
|a Proto-Oncogene Proteins c-raf
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.1
|2 NLM
|
| 650 |
|
7 |
|a Protein Kinase C
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.13
|2 NLM
|
| 650 |
|
7 |
|a Mitogen-Activated Protein Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.24
|2 NLM
|
| 650 |
|
7 |
|a Phospholipases A
|2 NLM
|
| 650 |
|
7 |
|a EC 3.1.1.32
|2 NLM
|
| 650 |
|
7 |
|a Type C Phospholipases
|2 NLM
|
| 650 |
|
7 |
|a EC 3.1.4.-
|2 NLM
|
| 650 |
|
7 |
|a Phospholipase D
|2 NLM
|
| 650 |
|
7 |
|a EC 3.1.4.4
|2 NLM
|
| 650 |
|
7 |
|a GTP-Binding Proteins
|2 NLM
|
| 650 |
|
7 |
|a EC 3.6.1.-
|2 NLM
|
| 650 |
|
7 |
|a ras Proteins
|2 NLM
|
| 650 |
|
7 |
|a EC 3.6.5.2
|2 NLM
|
| 650 |
|
7 |
|a Calcium
|2 NLM
|
| 650 |
|
7 |
|a SY7Q814VUP
|2 NLM
|
| 700 |
1 |
|
|a Gilfillan, A M
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 99(2001), 2 vom: 15. Mai, Seite 198-210
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:99
|g year:2001
|g number:2
|g day:15
|g month:05
|g pages:198-210
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 99
|j 2001
|e 2
|b 15
|c 05
|h 198-210
|